Trials / Completed
CompletedNCT02137382
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Creon® | active comparator |
| DRUG | Creon N | experimental drug |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-05-13
- Last updated
- 2016-01-22
- Results posted
- 2015-11-27
Locations
7 sites across 2 countries: Hungary, Spain
Source: ClinicalTrials.gov record NCT02137382. Inclusion in this directory is not an endorsement.